MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Abstract
Chronic treatments with antidepressants active on major depressive disorders influence pathways involved in cell survival and plasticity. As astrocytes seem to play a key role in the protection of brain cells, we investigated in these cells the rapid effects of the antidepressant fluoxetine (Prozac) on signaling cascades and gene induction, which probably play a role in neuroprotection. We show here that fluoxetine alone activates the extracellular signal-regulated-protein kinase (Erk) and p38 mitogen-associated protein (MAP) kinase cascades. RT-PCR revealed that genes, modulated in brain by long-term fluoxetine treatment, are rapidly induced by fluoxetine in cultured astrocytes: brain-derived nerve factor (BDNF) and its receptors, glial-derived nerve factor (GDNF) and deiodinase 3 (D3). Induction of D3 by fluoxetine is inhibited by U0126 and SB203580, suggesting that Erk and p38 MAP kinases are involved. Glial-derived nerve factor (GDNF) induction by fluoxetine is prevented by U0126, suggesting that Erk is implicated. Brain-derived nerve factor (BDNF) induction seems mediated by other signaling pathways. In conclusion, we show that fluoxetine alone rapidly activates mitogen activated protein (MAP) kinase cascades in rat astrocytes and that genes involved in neuroprotection are induced in a few hours in a MAP kinase-dependent or -independent manner.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MAPK1 activation is altered after stress and corticosterone exposure, and MAPK signaling was proposed to regulate antidepressant modulation of glial cell line-derived neurotrophic factor.
“It is known that MAPK1 activation is altered after stress [31] and corticosterone exposure [32] and that MAPK signaling was proposed to regulate AD modulation of glial cell line-derived neurotrophic factor [33].”
From The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes (2023) · cites this paper as [33]
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311 · see citing works
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · see citing works
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · see citing works
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561 · see citing works
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395 · see citing works
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380 · see citing works
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · see citing works
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206 · see citing works
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · see citing works
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81311-2 · Cited by 1,169 · see citing works
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164 · see citing works
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2000) · Synapse · doi:10.1002/1098-2396(20010101)39:1 · Cited by 934 · see citing works
Neuronal plasticity and survival in mood disorders
Duman, R. S., Malberg, J., Nakagawa, S., & D’Sa, C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00935-5 · Cited by 652 · see citing works
Neural plasticity to stress and antidepressant treatment
Duman, R. S., Malberg, J. E., & Thome, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00177-8 · Cited by 644 · see citing works
FGF and stress regulate CREB and ATF‐1 via a pathway involving p38 MAP kinase and MAPKAP kinase‐2.
Tan, Y., Rouse, J. W., Zhang, A., Cariati, S., Cohen, P., & Comb, M. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00840.x · Cited by 634 · see citing works
Antidepressants and neuroplasticity
D'Sa, C. M., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 516 · see citing works
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 475 · see citing works
Regulation of adult neurogenesis by antidepressant treatment
Duman, R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00358-x · Cited by 463 · see citing works
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 439 · see citing works
Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression
Russo-Neustadt, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00059-7 · Cited by 411 · see citing works
Yuan, P., Huang, L., Jiang, Y., Gutkind, J. S., Manji, H. K., & Chen, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104309200 · Cited by 332 · see citing works
Effects of Stress on Neurotrophic Factor Expression in the Rat Brain
SMITH, M. A., Makino, S., Květňanský, R., & Post, R. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44684.x · Cited by 255 · see citing works
Manji, H. K., & Lenox, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00235-8 · Cited by 241 · see citing works
Tu, H. M., Légrádi, G., Bartha, T., Salvatore, D., Lechan, R. M., & Larsen, P. R. (1999) · Endocrinology · doi:10.1210/endo.140.2.6486 · Cited by 198 · see citing works
A colorimetric method for the determination of submicrogram quantities of protein
McKnight, G. S. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90011-2 · Cited by 180 · see citing works
Expanding the horizons of depression: beyond the monoamine hypothesis
Hindmarch, I. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.288 · Cited by 143 · see citing works
Hisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M., & Yamawaki, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00531.x · Cited by 133 · see citing works
Lithium regulates PKC‐mediated intracellular cross‐talk and gene expression in the CNS in vivo
Chen, G., Masana, M. I., & Manji, H. K. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20303.x · Cited by 90 · see citing works
Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells
Chen, Y., Peng, L., Zhang, X., Stolzenburg, J., & Hertz, L. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00082-p · Cited by 68 · see citing works
Thyroid hormone metabolism by glial cells in primary culture
Courtin, F., Chantoux, F., & Francon, J. (1986) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(86)90039-0 · Cited by 62 · see citing works
Self-citationBaumgartner, A. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001887 · Cited by 60 · see citing works
Daniel, W. A., Wójcikowski, J., & Pałucha-Poniewiera, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704319 · Cited by 59 · see citing works
Induction of type III‐deiodinase activity in astroglial cells by retinoids
Esfandiari, A., Gagelin, C., Gavaret, J., Pavelka, S., Lennon, A., Pierre, M., & Courtin, F. (1994) · Glia · doi:10.1002/glia.440110306 · Cited by 57 · see citing works
Self-citationBartholomä, P., Erlandsson, N., Kaufmann, K., Rößler, O. G., Baumann, B., Wirth, T., Giehl, K. M., & Thiel, G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00882-1 · Cited by 56 · see citing works
Pallud, S. E., Ramaugé, M., Gavaret, J., Lennon, A., Munsch, N., Germain, D. L. S., Pierre, M., & Courtin, F. (1999) · Endocrinology · doi:10.1210/endo.140.6.6834 · Cited by 53 · see citing works
Self-citationEarly activation of transcription factor expression in Schwann cells by progesterone
MERCIER, G., Turque, N., & Schumacher, M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00311-4 · Cited by 51 · see citing works
Self-citationMurga, C., Fukuhara, S., & Gutkind, J. S. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00131-3 · Cited by 43 · see citing works
Bayer, T. A., Schramm, M., Feldmann, N., Knable, M. B., & Falkai, P. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00115-9 · Cited by 41 · see citing works
Induction of Type 3 Iodothyronine Deiodinase by Nerve Injury in the Rat Peripheral Nervous System
Li, W. W., Goascogne, C. L., Ramaugé, M., Schumacher, M., Pierre, M., & Courtin, F. (2001) · Endocrinology · doi:10.1210/endo.142.12.8532 · Cited by 34 · see citing works
Self-citationPharmacological mechanisms of T3 augmentation of antidepressant action
Newman, M. E., Agid, O., Gur, E., & Lerer, B. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001875 · Cited by 23 · see citing works
Activation of S6 kinase in astroglial cells by FGFa and FGFb
Gavaret, J. M., Matricon, C., Pomérance, M., Jacquemin, C., Toru‐Delbauffe, D., & Pierre, M. (1989) · Developmental Brain Research · doi:10.1016/0165-3806(89)90009-6 · Cited by 19 · see citing works
Self-citationThyroid hormones in treatment of mood disorders.
Chakrabarti, S., & Malhotra (2001) · PubMed · Cited by 3 · see citing works
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 649 · see citing works
Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B. C., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 352 · see citing works
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324 · see citing works
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305 · see citing works
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · see citing works
The neurodevelopmental origins of suicidal behavior
Turecki, G., Ernst, C., Jollant, F., Labonté, B., & Mechawar, N. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.008 · Cited by 299 · see citing works
Rao, J. S., Ertley, R. N., Lee, H.-J., DeMar, J. C., Arnold, J. T., Rapoport, S. I., & Bazinet, R. P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001888 · Cited by 280 · see citing works
RetractedErnst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.22 · Cited by 235 · see citing works
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222 · see citing works
Lu, D., Tsao, Y.-Y., Leung, Y., & Su, K. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.98 · Cited by 180 · see citing works
Levkovitz, Y., Gil‐Ad, I., Zeldich, E., Dayag, M., & Weizman, A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:029 · Cited by 172 · see citing works
Peng, C., Chiou, S., Chen, S., Chou, Y., Ku, H., Cheng, C., Yen, C.-J., Tsai, T., Chang, Y., & Kao, C.-L. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.002 · Cited by 145 · see citing works
Neurotrophic factors (BDNF and GDNF) and the serotonergic system of the brain
Popova, N. K., Ilchibaeva, T. V., & Naumenko, V. S. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030099 · Cited by 143 · see citing works
Antidepressants act directly on astrocytes: Evidences and functional consequences
Czéh, B., & Benedetto, B. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.017 · Cited by 129 · see citing works
Dwivedi, Y., Rizavi, H. S., Conley, R. R., & Pandey, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001744 · Cited by 123 · see citing works
Hodge, J. M., Wang, Y., Berk, M., Collier, F., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.003 · Cited by 122 · see citing works
The neurotrophic and neuroprotective effects of psychotropic agents
Hunsberger, J. G., Austin, D. R., Henter, I. D., & Chen, G. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/jhunsberger · Cited by 122 · see citing works
Caso, J. R., MacDowell, K. S., González-Pinto, A. M., García, S., de Diego-Adeliño, J., Carceller‐Sindreu, M., Sarramea, F., Caballero‐Villarraso, J., Gracia‐García, P., de la Cámara, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01755-3 · Cited by 109 · see citing works
Li, B., Zhang, S., Zhang, H., Nu, W., Cai, L., Hertz, L., & Peng, L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1306-5 · Cited by 109 · see citing works
Driving GDNF expression: The green and the red traffic lights
Saavedra, A., Baltazar, G., & Duarte, E. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.006 · Cited by 108 · see citing works
Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors
Ohno, Y., Hibino, H., Lossin, C., Inanobe, A., & Kurachi, Y. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.018 · Cited by 104 · see citing works
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101 · see citing works
Therapeutic Potential of Fluoxetine in Neurological Disorders
Mostert, J. P., Koch, M. W., Heerings, M. A. P., Heersema, D. J., & Keyser, J. D. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00040.x · Cited by 101 · see citing works
Mostert, J. P., Behloul, F., Hoogduin, J. M., Luyendijk, J. M., Heersema, D. J., van Buchem, M. A., & Keyser, J. D. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.139345 · Cited by 100 · see citing works
Qi, D., Ouyang, C., Wang, Y., Zhang, S., Ma, X., Song, Y., Yu, H., Tang, J., Fu, W. E., Sheng, L., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.031 · Cited by 94 · see citing works
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92 · see citing works
Drzyzga, Ł., Marcinowska, A., & Obuchowicz, E. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.03.009 · Cited by 92 · see citing works
Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients
Zhang, X., Zhang, Z., Xie, C., Xi, G., Zhou, H., Zhang, Y., & Sha, W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.004 · Cited by 88 · see citing works
Kipp, M., Karakaya, S., Pawlak, J., de Araújo, G. W., Arnold, S., & Beyer, C. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.07.001 · Cited by 87 · see citing works
Ubhi, K. K., Inglis, C. A., Mante, M., Patrick, C., Adame, A., Spencer, B. J., Rockenstein, E. M., May, V. E. L., Winkler, J., & Masliah, E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.008 · Cited by 87 · see citing works
Kajitani, N., Hisaoka‐Nakashima, K., Morioka, N., Okada‐Tsuchioka, M., Kaneko, M., Kasai, M., Shibasaki, C., Nakata, Y., & Takebayashi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051197 · Cited by 85 · see citing works
5-HT2 ligands in the treatment of anxiety and depression
Quesseveur, G., Nguyen, H. T., Gardier, A. M., & Guiard, B. P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.719872 · Cited by 84 · see citing works
Future antidepressant targets: neurotrophic factors and related signaling cascades
Schmidt, H. D., Banasr, M., & Duman, R. S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.003 · Cited by 83 · see citing works
Targeting astrocytes in major depression
Peng, L., Verkhratsky, A., Gu, L., & Li, B. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1095094 · Cited by 83 · see citing works
Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80 · see citing works
Diversiform Etiologies for Post-stroke Depression
Wang, Z., Shi, Y., Liu, F., Jia, N., Gao, J., Pang, X., & Deng, F. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00761 · Cited by 81 · see citing works
Đurić, V., & Duman, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1020-7 · Cited by 78 · see citing works
Michel, T. M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., Zoechling, R., & Grünblatt, E. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.06.001 · Cited by 78 · see citing works
Marton, S., González, B., Rodríguez-Bottero, S., Miquel, E., Palma, L. M., Pazos, M., Prieto, J. P., Rodríguez, P., Sameš, D., Seoane, G. A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00193 · Cited by 74 · see citing works
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706766 · Cited by 73 · see citing works
Huang, S. A., Mulcahey, M. A., Crescenzi, A., Chung, M., Kim, B. W., Barnes, C., Kuijt, W. J., Turano, H., Harney, J. W., & Larsen, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0173 · Cited by 73 · see citing works
Morioka, N., Suekama, K., Zhang, F. F., Kajitani, N., Hisaoka‐Nakashima, K., Takebayashi, M., & Nakata, Y. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12614 · Cited by 73 · see citing works
Hung, S., Liou, H., & Fu, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.003 · Cited by 73 · see citing works
Stepulak, A., Rzeski, W., Sifringer, M., Brocke, K. S., Gratopp, A., Kupisz, K., Turski, L., & Ikonomidou, C. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6664 · Cited by 73 · see citing works
Huang, Y.-Y., Peng, C.-H., Yang, Y.-P., Wu, C.-C., Hsu, W., Wang, H.-J., Chan, K.-H., Chou, Y., Chen, S., & Chang, Y.-L. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061255 · Cited by 65 · see citing works
Hertz, L., Rothman, D. L., Li, B., & Peng, L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00025 · Cited by 66 · see citing works
Anderson, G., & Maes, M. H. J. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140711091400 · Cited by 64 · see citing works
Intracellular signaling pathways pave roads to recovery for mood disorders
Tanis, K. Q., & Duman, R. S. (2007) · Annals of Medicine · doi:10.1080/07853890701483270 · Cited by 63 · see citing works
Epigenetics and Suicidal Behavior Research Pathways
Turecki, G. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.06.011 · Cited by 62 · see citing works
Ha, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 60 · see citing works
5-HTT independent effects of fluoxetine on neuroplasticity
Levy, M. J. F., Boulle, F., Emerit, M. B., Poilbout, C., Steinbusch, H. W. M., van den Hove, D., Kenis, G., & Lanfumey, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-42775-w · Cited by 57 · see citing works
Hisaoka, K., Tsuchioka, M., Yano, R., Maeda, N., Kajitani, N., Morioka, N., Nakata, Y., & Takebayashi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224683 · Cited by 57 · see citing works
Thyroid Hormone Deiodinases in the Central and Peripheral Nervous System
Courtin, F., Zrouri, H., Lamirand, A., Li, W. W., MERCIER, G., Schumacher, M., Goascogne, C. L., & Pierre, M. (2005) · Thyroid · doi:10.1089/thy.2005.15.931 · Cited by 56 · see citing works
Self-citationFluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis
Mostert, J. P., Sijens, P. E., Oudkerk, M., & Keyser, J. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.042 · Cited by 56 · see citing works
Franco, J. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.012 · Cited by 57 · see citing works
Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients
Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., & Zhang, Y. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.003 · Cited by 55 · see citing works
Astrocytic β2-adrenergic receptors: From physiology to pathology
Laureys, G., Clinckers, R., Gerlo, S., Spooren, A., Wilczak, N., Kooijman, R., Smolders, I. J., Michotte, Y. M., & Keyser, J. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.011 · Cited by 55 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001550 · Cited by 54 · see citing works
Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., & Zhang, Y. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.011 · Cited by 54 · see citing works
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1631-3 · Cited by 52 · see citing works
Nie, H., Peng, Z., Ning, L., Wang, H., Chen, Y., Fang, Z., Hou, W., Gao, F., Li, X., Xiong, L., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.002 · Cited by 52 · see citing works
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A. M., & Guiard, B. P. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 51 · see citing works
Nordenberg (2010) · International Journal of Oncology · doi:10.3892/ijo_00000756 · Cited by 49 · see citing works
Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes
Lamirand, A., Pallud, S. E., Ramaugé, M., Pierre, M., & Courtin, F. (2008) · Endocrinology · doi:10.1210/en.2007-1462 · Cited by 48 · see citing works
Self-citationAlmeida, R. C., Granato‐Souza, D., Soletti, R. C., López, M. G., Rodrigues, A. L. S., & Gabilan, N. H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.057 · Cited by 49 · see citing works
Huang, W. C., Zhao, Y. C., Zhu, X., Cai, Z., Wang, S., Yao, S., Qi, Z., & Xie, P. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9822-5 · Cited by 47 · see citing works
Calati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.005 · Cited by 45 · see citing works
Tsybko, A. S., Ilchibaeva, T. V., & Popova, N. K. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0063 · Cited by 46 · see citing works
Villegas, S. N., Njaine, B., Linden, R., & Carri, N. G. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.08.014 · Cited by 44 · see citing works
Domin, H., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Śmiałowska, M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.019 · Cited by 43 · see citing works
Lu, D., Leung, Y., & Su, K. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000338 · Cited by 43 · see citing works
Shadfar, S., Kim, Y.-G., Katila, N., Neupane, S., Ojha, U., Bhurtel, S., Srivastav, S., Jeong, G., Park, P., Hong, J. T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0342-0 · Cited by 42 · see citing works
Lee, H., Rao, J. S., Ertley, R. N., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0582-1 · Cited by 42 · see citing works
RetractedRao, J. S., Ertley, R. N., Lee, H.-J., Rapoport, S. I., & Bazinet, R. P. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500391 · Cited by 40 · see citing works
RetractedPrenatal SSRI exposure: Effects on later child development
Hermansen, T. K., & Melinder, A. (2015) · Child Neuropsychology · doi:10.1080/09297049.2014.942727 · Cited by 38 · see citing works
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance
Benmansour, S., Privratsky, A. A., Adeniji, O. S., & Frazer, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300165x · Cited by 38 · see citing works
Ruban, A., Avissar, S., & Schreiber, G. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.007 · Cited by 38 · see citing works
The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve
Zrouri, H., Goascogne, C. L., Li, W. W., Pierre, M., & Courtin, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03641.x · Cited by 37 · see citing works
Self-citationAmit, B. H., Gil‐Ad, I., Taler, M., Bar, M., Zolokov, A., & Weizman, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.003 · Cited by 37 · see citing works
Daniele, S., Zappelli, E., & Martini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0446-x · Cited by 36 · see citing works
Memory in astrocytes: a hypothesis
Caudle, R. M. (2006) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-3-2 · Cited by 37 · see citing works
Liu, X., Li, P., Ma, X., Zhang, J., Sun, X., Luo, X., & Zhang, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.041 · Cited by 34 · see citing works
Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia
Páv, M., Kovárů, H., Fišerová, A., Havrdová, E., & Lisá, V. (2008) · Physiological Research · doi:10.33549/physiolres.930990 · Cited by 34 · see citing works
Avissar, S., & Schreiber, G. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.003 · Cited by 33 · see citing works
Chilmończyk, Z., Bojarski, A. J., Pilc, A., & Sylte, I. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.011 · Cited by 31 · see citing works
Peng, Z., Zhang, R., Wang, H., Chen, Y., Xue, F., Wang, L., Yang, F., Chen, Y., Liu, L., Kuang, F., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.032 · Cited by 30 · see citing works
Pawluski, J. L. (2011) · Neuroendocrinology · doi:10.1159/000329293 · Cited by 30 · see citing works
Fluoxetin upregulates connexin 43 expression in astrocyte.
Mostafavi, H., Khaksarian, M., Joghataei, M. T., Hassanzadeh, G., Soleimani, M., Eftekhari, S., Soleimani, M., Mousavizadeh, K., & Hadjighassem, M. (2014) · PubMed Central · Cited by 30 · see citing works
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 29 · see citing works
Satyanarayanan, S. K., Shih, Y.-H., Chien, Y.-C., Huang, S., Gałecki, P., Kasper, S. F., Chang, J. P., & Su, K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0899-x · Cited by 28 · see citing works
Astrocytic transactivation by α2A-adrenergic and 5-HT2B serotonergic signaling
Peng, L., Li, B., Du, T., Kong, E. K. C., Hu, X., Zhang, S., Shan, X., & Zhang, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.018 · Cited by 28 · see citing works
Paumier, K. L., Sortwell, C. E., Madhavan, L., Terpstra, B. T., Daley, B. F., & Collier, T. J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.005 · Cited by 28 · see citing works
Regulators of G-protein-coupled receptor–G-protein coupling: antidepressants mechanism of action
Schreiber, G., & Avissar, S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.75 · Cited by 27 · see citing works
Antidepressants for neuroprotection in Huntington's disease: A review
Jamwal, S., & Kumar, P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.033 · Cited by 27 · see citing works
Shi, Y., Yuan, Y., Xu, Z., Pu, M., Wang, C., Zhang, Y., Liu, Z., Wang, C., Li, L., & Zhang, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.030 · Cited by 26 · see citing works
Cunha, M. P., Budni, J., Pazini, F. L., Oliveira‐Giacomelli, Á., Rosa, J. M., Lopes, M. W., Leal, R. B., & Rodrigues, A. L. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.004 · Cited by 26 · see citing works
Ramos-Hryb, A. B., Cunha, M. P., Pazini, F. L., Lieberknecht, V., Prediger, R. D., Kaster, M. P., & Rodrigues, A. L. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.05.009 · Cited by 26 · see citing works
β-Arrestin signaling complex as a target for antidepressants and as a depression marker
Schreiber, G., Golan, M., & Avissar, S. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.8.1413787 · Cited by 25 · see citing works
Olianas, M. C., Dedoni, S., & Onali, P. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236455 · Cited by 24 · see citing works
- Authors
- Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M.
- Affiliations
- Inserm (FR)
- Corresponding author
- Mercier, Gilles
- Venue
- Journal of Molecular Neuroscience
- Published
- 2004
- Volume
- 24
- Issue
- 2
- Pages
- 207-216
- ISSN
- 0895-8696 (ISSN-L)
- OpenAlex
- W1996567906
- Cited by
- 176
- References
- 47
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 10 · 2014: 19 · 2013: 11 · 2012: 14
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, astrocytes, MAPK signaling, ERK, p38 MAPK, antidepressants, neuroprotection, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, gene expression, major depressive disorder, U0126, SB203580
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Enzyme Activation, Fluoxetine, Gene Expression Regulation, Nerve Growth Factors, Nerve Tissue Proteins, Proto-Oncogene Proteins, Signal Transduction, Transcriptional Activation, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Antidepressive Agents, Second-Generation, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Glial Cell Line-Derived Neurotrophic Factor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review